Longview Acquisition Corp. II (LGV) News

Longview Acquisition Corp. II (LGV): $9.78

0.01 (+0.10%)

POWR Rating

Component Grades













Filter LGV News Items

LGV News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

Latest LGV News From Around the Web

Below are the latest news stories about Longview Acquisition Corp II that investors may wish to consider to help them evaluate LGV as an investment opportunity.

HeartFlow, Longview Acquisition SPAC Deal Called Off

HeartFlow Holding Inc and a special purpose acquisition company, Longview Acquisition Corp II (NYSE: LGV ), have called off merger plans that would have taken the cardiac test company public. HeartFlow described the move as a mutual decision a "result of current unfavorable market conditions." Affiliates of Glenview … Full story available on Benzinga.com

Benzinga | February 7, 2022

HeartFlow cancels plans to go public in SPAC merger

It joins a growing number of SPAC deals called off amid stock market turbulence, which also has dampened what had been a record run of initial public offerings.

Yahoo | February 5, 2022

HeartFlow Announces Mutual Termination of Business Combination Agreement

REDWOOD CITY, Calif., Feb. 04, 2022 (GLOBE NEWSWIRE) -- HeartFlow Holding, Inc. (“HeartFlow”), the leader in revolutionizing precision heart care, today announced that it and Longview Acquisition Corporation II (NYSE: LGV), a special purpose acquisition company sponsored by affiliates of Glenview Capital Management, LLC, have mutually agreed to terminate their previously announced business combination agreement, effective immediately, as a result of current unfavorable market conditions. About H

Yahoo | February 4, 2022

What Type Of Shareholders Own The Most Number of Longview Acquisition Corp. II (NYSE:LGV) Shares?

The big shareholder groups in Longview Acquisition Corp. II ( NYSE:LGV ) have power over the company. Insiders often...

Yahoo | October 7, 2021

Moore Kuehn Encourages HBMD, STFC, CVA and LGV Investors to Contact Law Firm

NEW YORK, July 21, 2021 (GLOBE NEWSWIRE) -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential claims concerning whether the following proposed mergers are fair to shareholders. Moore Kuehn may seek increased consideration, additional disclosures, or other relief on behalf of the shareholders of these companies: Howard Bancorp, Inc. (NASDAQ: HBMD) Howard Bancorp has agreed to merge with FNB. Under the propo

Yahoo | July 21, 2021

Heartflow Charts NYSE Debut IPO Via $2.4B SPAC Deal

Heartflow Holding Inc (NYSE: HFLO) aims to bring its noninvasive, artificial intelligence (AI)-based test for coronary heart disease to more doctors and patients via a SPAC merger with Longview Acquisition Corp II (NYSE: LGV). Once the deal, valued at an enterprise value of about $2.4 billion, is complete, the resulting public company will operate under HeartFlow's banner with the NYSE ticker HFLO. The company offers a test that uses artificial intelligence to build an individualized map of each

Yahoo | July 16, 2021

SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Longview Acquisition Corp. II (NYSE:LGV)

BALA CYNWYD, PA / ACCESSWIRE / July 15, 2021 / Law office of Brodsky & Smith announces that it is investigating potential claims against the Board of Directors of Longview Acquisition Corp. II ("Longview II" or the "Company") (NYSE:LGV) for possible breaches of fiduciary duty and other violations of federal and state law in connection with a merger agreement pursuant to which Longview II, a special purpose acquisition company, will combine with HeartFlow Holding, Inc.

Yahoo | July 15, 2021

HeartFlow, the Leader in Precision Heart Care, Announces Merger with Longview Acquisition Corp. II to Become a Publicly Traded Company

REDWOOD CITY, Calif. & NEW YORK, July 15, 2021--HeartFlow Holding, Inc. ("HeartFlow", or the "Company"), the leader in revolutionizing precision heart care, and Longview Acquisition Corp. II (NYSE: LGV) ("Longview"), a special purpose acquisition company sponsored by affiliates of Glenview Capital Management, LLC ("Glenview"), announced today that they have entered into a definitive business combination agreement that will support HeartFlow’s vision of revolutionizing precision heart care. Upon

Yahoo | July 15, 2021

Longview Acquisition Corp. II Provides Update on Periodic Reporting

Longview Acquisition Corp. II (NYSE: LGV) (the "Company") announced today that it had received a notice from the New York Stock Exchange (the "NYSE") indicating that the Company is not in compliance with Section 802.01E of the NYSE Listed Company Manual as a result of its failure to timely file its Quarterly Report on Form 10-Q for the quarter ended March 31, 2021 (the "Q1 2021 Form 10-Q") with the Securities and Exchange Commission (the "SEC").

Yahoo | June 1, 2021

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Page generated in 0.4958 seconds.